baicalin has been researched along with lincomycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; Dai, C; He, MY; Hu, YX; Li, H; Li, RM; Li, Z; Long, D; Si, ZP; Su, W; Wang, G; Wang, J; Xie, YH; Yang, X; Zhao, R | 1 |
| Chen, L; Han, H; Tang, S; Zhang, H; Zhang, S; Zhong, R | 1 |
2 other study(ies) available for baicalin and lincomycin
| Article | Year |
|---|---|
Gut-Lung Dysbiosis Accompanied by Diabetes Mellitus Leads to Pulmonary Fibrotic Change through the NF-κB Signaling Pathway.
Topics: Animals; Anti-Infective Agents; Diabetes Mellitus, Experimental; Disease Models, Animal; Dysbiosis; Fecal Microbiota Transplantation; Flavonoids; Gastrointestinal Microbiome; Intestines; Lincomycin; Lung; Mice; Mice, Inbred C57BL; Microbiota; NF-kappa B; Pulmonary Fibrosis; Signal Transduction; Streptozocin | 2021 |
Baicalin Alleviates Short-Term Lincomycin-Induced Intestinal and Liver Injury and Inflammation in Infant Mice.
Topics: Animals; Anti-Bacterial Agents; Child, Preschool; Flavonoids; Humans; Inflammation; Lincomycin; Lipids; Liver; Mice; Mice, Inbred C57BL | 2022 |